A Letter to Caribbean Pharmacies

On Digital Transformation, Responsibility, and the Work Ahead

To our colleagues in community pharmacies, hospital dispensaries, supply warehouses, and regulatory offices across the Caribbean,

Pharmacy has always been more than distribution. It is where diagnosis meets treatment.  Where prescribers meet dispensers.  Where patients meet affordability.  Where science meets trust.

In small island systems especially, pharmacies are not peripheral to care — they are central to its stability. When medicines are unavailable, delayed, unaffordable, or misused, the entire health system feels it immediately. And when pharmacy works well, the system quietly holds together.

Those of us working in health system leadership see this clearly. We also see something else: the work is getting harder. Medication regimens are more complex. Chronic disease burden is rising. Global supply chains are fragile. Regulatory expectations are tightening. Digital systems are emerging unevenly. Market structures are shifting. Public trust, once assumed, must now be actively maintained.

And through all of this, pharmacists continue to serve — often stretched, often adapting, often compensating for weaknesses elsewhere in the system. This letter is written in respect for that work. But also with urgency. Because digitisation is reshaping pharmacy across the world. And in the Caribbean, it presents both risk and opportunity.

The Pharmacy Problem Is Not Technology — It Is Complexity

Across our region, medication error, suboptimal prescribing, stockouts, fragmented formulary management, and inconsistent data visibility are persistent challenges. They do not arise from negligence. They arise from structural complexity.

Manual inventory management.  Disconnected ordering and dispensing systems. Different drug lists across facilities and payors.  Limited visibility into utilisation trends.  Weak integration between prescribing, claims, and supply.

Digital tools can help address these realities. But technology alone does not simplify complexity. If poorly integrated, it adds to it. Pharmacy digitisation that is layered onto old processes without redesign will increase workload, multiply reconciliation tasks, and create parallel systems. We have seen this pattern in other domains of digital health. We must not repeat it here.

What Good Can Look Like

Digital pharmacy transformation, when done intentionally, strengthens four interconnected areas.

Safer Prescribing Through Integrated e-Prescribing and Clinical Decision Support

When prescribing systems are linked to real-time decision support, medication errors can be reduced significantly. Drug–drug interactions, contraindications, unsafe dosing, and duplications can be flagged before harm occurs.

But alerts must be contextual. They must reflect local formularies, population-specific dosing realities, and resistance patterns. Otherwise, they become noise. For Caribbean systems, the real value lies in embedding our own treatment guidelines and constraints into prescribing workflows — strengthening rational use while preserving clinical judgment.

Real-Time Inventory and Supply Chain Visibility

Stockouts are not merely logistical inconveniences. They are clinical events. A patient whose medication is unavailable does not experience a supply chain failure; they experience interrupted care.

Connected inventory systems across facilities can reduce wastage, improve forecasting, and prevent parallel ordering. In small markets especially, visibility matters. Shared transparency reduces duplication and increases resilience. Digital supply intelligence is not about control. It is about continuity.

Connected Prescribing, Claims, and Formulary Governance

Prescription data becomes powerful when connected to reimbursement and formulary systems. When these layers align, systems can move from reactive cost containment to proactive utilisation strategy.

This is particularly important in small states where affordability pressures are acute and where market structure can influence access. Transparency in how prescribing patterns relate to formulary policy and payment rules strengthens legitimacy. Digital transformation in pharmacy should increase clarity — not suspicion.

Patient-Centred Digital Engagement

Digital pharmacy is not only about internal optimisation. It reshapes patient experience: electronic reminders, access to medication history, clearer labelling, adherence support. In a region facing high burdens of diabetes, hypertension, and cardiovascular disease, adherence is not optional. It is outcome-defining. But digital engagement must be equitable. Connectivity, literacy, and language realities must shape design. We cannot assume digital access; we must design for inclusion.

The Real Blockers

If digital pharmacy transformation is so promising, why is progress uneven?

Because the barriers are not technical.

Governance fragmentation means pharmacy digitisation is sometimes treated as logistics rather than as clinical and financing strategy. Procurement decisions are made without shared standards, creating silos that cannot communicate. Workforce capacity is stretched; new systems are introduced without workflow redesign. Drug master data is inconsistent, undermining analytics and safety tools alike.

None of these challenges are unique to one island. They are regional realities. And they are solvable — but only collectively.

Where We Must Go Next

Digital pharmacy transformation cannot be a race for features. It must be a commitment to coherence.

That means:

• Building standards-based data architectures that allow prescribing, dispensing, inventory, and claims systems to speak a common language.
  
  
• Aligning governance across clinical, supply, and financing domains so that pharmacy is not treated as an island within the health system.
  
  
• Redesigning workflows so that digital tools reduce burden rather than shifting administrative weight onto pharmacists and clinicians.
  
  
• Measuring success not by system utilisation, but by safer prescribing, fewer stockouts, lower waste, and improved adherence.

This work requires discipline. It requires cooperation across independent and corporate pharmacies, hospitals, ministries, insurers, and regulators. It requires difficult conversations about data sharing, accountability, and role boundaries.

It also requires trust.

A Call to the Profession

Pharmacy in the Caribbean has always been adaptive. It has navigated supply shocks, economic constraints, evolving regulation, and public expectation shifts. It has done so with professionalism and resilience.

Digital transformation is not a threat to that identity. If shaped deliberately, it is a tool to strengthen it. But we cannot allow digital systems to merely run faster while fragmentation deepens. Nor can we allow fear of change to freeze progress.

The question before us is not whether pharmacy will digitise. It already is. The question is whether we will shape that digitisation in a way that protects safety, strengthens equity, preserves professional integrity, and builds systems worthy of public trust. Digital pharmacy transformation is no longer optional. It is a structural necessity. And shaping it well requires collaboration across independent, corporate, hospital, and regulatory domains.

This letter is written in partnership, not prescription.

We respect the work you do. We believe it matters. And we believe that together, we can do it even better.

With respect and resolve,

All of We

On behalf of colleagues committed to strengthening Caribbean health systems